Immunologic behaviour before and during cytostatic treatment in bronchus carcinoma.
D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007109:Immunity; D007136:Immunoglobulins; D008213:Lymphocyte Activation; D008727:Methotrexate / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D003520:Cyclophosphamide; D008727:Methotrexate